SCHEMBL1139716

SCHEMBL1139716

O=C(O)CC(O)CCCC1CO1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 4/20 0.47
SLC22A6 Q4U2R8 1/20 0.43
GABRR1 P24046 2/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.34
MMP12 P39900 3/20 0.33
MMP13 P45452 3/20 0.33
MMP2 P08253 1/20 0.33
MMP9 P14780 1/20 0.33
MMP14 P50281 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
FFAR1 O14842 1/20 0.31
TBXA2R P21731 1/20 0.30
PTGFR P43088 1/20 0.30
PTGER2 P43116 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5056493 1.00 GPR84 (0.47) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL5056485 1.00 GPR84 (0.47) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL6706217 0.95 GPR84 (0.50) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL6706261 0.93 GPR84 (0.53) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL6706270 0.89 SLC22A6 (0.46) GPR84SLC22A6GABRR1LMNAMAPT
SCHEMBL15425737 0.82 ALDH1A1 (0.44) ALDH1A1
SCHEMBL2066730 0.76 SLC22A6 (0.50) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL2066729 0.76 SLC22A6 (0.50) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL14346068 0.76 SLC22A6 (0.50) GPR84SLC22A6GABRR1LMNAALDH1A1
SCHEMBL6035097 0.76 SLC22A6 (0.50) GPR84SLC22A6GABRR1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253160-B1 Electrophotographic encapsulated toner particles and method for making them CANON KK (JP) 2011-02-23 EP disclosed
US-7632618-B2 Polyhydroxyalkanoate-containing structure and manufacturing method thereof CANON KABUSHIKI KAISHA (JP) 2009-12-15 US disclosed
US-7615233-B2 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KABUSHIKI KAISHA (JP) 2009-11-10 US disclosed
US-7527809-B2 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof CANON KABUSHIKI KAISHA (JP) 2009-05-05 US disclosed
US-7527963-B2 Acetyl-CoA acyltransferase gene disrupted bacterium for producing polyhydroxyalkanoate and method for producing polyhydroxyalkanoate using the same CANON KABUSHIKI KAISHA (JP) 2009-05-05 US disclosed
EP-1275378-B1 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KK (JP) 2009-04-15 EP disclosed
US-20090061498-A1 POLYHYDROXYALKANOATE-CONTAINING STRUCTURE AND MANUFACTURING METHOD THEREOF CANON KABUSHIKI KAISHA (JP) 2009-03-05 US disclosed
US-20090029423-A1 METHOD FOR SEPARATING TARGET COMPONENT CANON KABUSHIKI KAISHA (JP) 2009-01-29 US disclosed
EP-1254930-B1 Particles for electrophoresis, a production method thereof and a display using the particles CANON KK (JP) 2008-06-18 EP disclosed
EP-1275728-B1 Polyhydroxyalkanoate-containing structure and manufacturing method thereof CANON KK (JP) 2008-06-04 EP disclosed
US-20030194443-A1 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KABUSHIKI KAISHA (JP) 2003-10-16 US disclosed
US-20030118931-A1 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KABUSHIKI KAISHA (JP) 2003-06-26 US disclosed
US-20030104302-A1 Construct and method for making it LASALLE BANK NATIONAL ASSOCIATION 2003-06-05 US disclosed
EP-1275728-A1 Polyhydroxyalkanoate-containing structure and manufacturing method thereof CANON KABUSHIKI KAISHA (JP) 2003-01-15 EP disclosed
EP-1275378-A2 Particulate construct comprising polyhydroxyalkanoate and method for producing it CANON KABUSHIKI KAISHA (JP) 2003-01-15 EP disclosed
EP-1262229-A1 Coloring composition containing a pigment coated by a polyhydroxyalkanoate CANON KABUSHIKI KAISHA (JP) 2002-12-04 EP disclosed
EP-1256606-A2 Pigment containing ink and production method thereof CANON KABUSHIKI KAISHA (JP) 2002-11-13 EP disclosed
EP-1254930-A2 Particles for electrophoresis, a production method thereof and a display using the particles CANON KABUSHIKI KAISHA (JP) 2002-11-06 EP disclosed
EP-1253160-A2 Construct and method for making it CANON KABUSHIKI KAISHA (JP) 2002-10-30 EP disclosed
EP-1253475-A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner CANON KABUSHIKI KAISHA (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030194443-A1 Particulate construct comprising polyhydroxyalkanoate and method for producing it SQLE, FDFT1, CYP51A1 GPR84 371/4885SLC22A6 1964/4885GABRR1 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.